During the past decade, Shaoxing Central Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shaoxing Central Hospital" #1 collaborator was "Jiaxing Hospital of T.C.M" with 1 trials as a collaborator, "Jinhua Municipal Central Hospital" with 1 trials as a collaborator, "SAHZU.CHANGXING CAMPUS" with 1 trials as a collaborator, "Shaoxing People's Hospital" with 1 trials as a collaborator and "Zhuji People's hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Shaoxing Central Hospital" are "Etanercept" (1 trials), "Psoriasis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Shaoxing Central Hospital" in a lesser frequency.

Most popular intervention types in "Shaoxing Central Hospital" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Glucocorticoid" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shaoxing Central Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Shaoxing Central Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Shaoxing Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shaoxing Central Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".